All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).
To receive Global Research’s Daily Newsletter (selected articles), click here.
Visit and follow us on Instagram, Twitter and Facebook. Feel free to repost and share widely Global Research articles.
***
Guest: Karen Kingston – Biotech Analyst and med-legal advisor with over 20 years of experience driving blockbuster commercialization efforts for medical devices and prescription therapies. Owner of Varitage Strategies (since 2014). Was once a Cardiovascular Sales Representative for the Northeast Region (NY) at Pfizer.
This session is about:
an Infants and Toddlers study by Pfizer:
“It is statistically and clinically impossible to conduct a clinical trial that will prove a vaccine will be more effective than a child’s natural immune system.“
BLA/FDA approval (not shielded by EUA research)
new insights into the 2-SP Spike:
“It’s a weaponized trimerized prefusion spike with 2 Proline modifications, aka optimized codons in Comirnaty and all other COVID-19 shots”
About the Operation Warp Speed contracts, especially the DoD/Pfizer contract
*
Note to readers: Please click the share buttons above or below. Follow us on Instagram, Twitter and Facebook. Feel free to repost and share widely Global Research articles.
Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]
www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the
copyright owner.
